Skip to main content
Erschienen in: Forensic Toxicology 2/2021

12.03.2021 | Original Article

Comparative study between active and passive exposure of methamphetamine vapor in mice

verfasst von: Kazumasa Abe, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa

Erschienen in: Forensic Toxicology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Heating methamphetamine (METH) crystal to produce vapor has been a method of substance abuse in young people since the mid-1990s. However, there are little data on the relationship between the urinary concentration of METH and exposure to METH vapor in humans. As a result, drug suspects sometimes claim in court that the METH detected in their urine was due to passive exposure. Therefore, this study aimed to clarify the different effects of active and passive METH exposure on urinary METH concentration in an animal model of METH vapor inhalation.

Methods

Mice were exposed to METH vapor under active exposure (conditions 1), mimicked passive exposure in a car (conditions 2), and mimicked passive exposure in a room (conditions 3). Urine was collected every 24 h after exposure for 96 h. The METH concentrations in the air in the chamber and urine were analyzed by gas chromatography-mass spectrometry.

Results

In conditions 1, METH was detected in the urine at a concentration significantly above the cut-off value, which was the screening kit’s detection limit, even after 72–96 h. On the other hand, in conditions 2 and 3, METH was detected in the urine at concentrations below the cut-off value in the first 24 h.

Conclusions

The present study was the first to reveal differences in urinary excretion of METH depending on its inhaled amount. When the results were extrapolated to humans, the amount of METH detected in the urine of the passively exposed subjects was extremely small, which was not detectable by the screening kit.
Literatur
5.
Zurück zum Zitat National Institute on Drug Abuse (NIDA) (2008) Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group, Highlights and Executive Summary. U.S. National Institute on Drug Abuse (NIDA) (2008) Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group, Highlights and Executive Summary. U.S.
9.
Zurück zum Zitat Howeedy A, Virtanen I, Laitinen L, Gould N, Koukoulis G, Gould V (1990) Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 63(6):798–806PubMed Howeedy A, Virtanen I, Laitinen L, Gould N, Koukoulis G, Gould V (1990) Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 63(6):798–806PubMed
12.
Zurück zum Zitat Hermens D, Lubman D, Ward P, Naismith S, Hickie I (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(S4):S22-25CrossRef Hermens D, Lubman D, Ward P, Naismith S, Hickie I (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(S4):S22-25CrossRef
14.
Zurück zum Zitat Lin L, Stefano E, Schmitz D, Hsu L, Ellis S, Lennard M, Tucker G, Cho A (1997) Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 25(9):1059–1064PubMed Lin L, Stefano E, Schmitz D, Hsu L, Ellis S, Lennard M, Tucker G, Cho A (1997) Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 25(9):1059–1064PubMed
15.
Zurück zum Zitat Oyler J, Cone E, Joseph R Jr, Moolchan E, Huestis M (2002) Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem 48(10):1703–1714CrossRef Oyler J, Cone E, Joseph R Jr, Moolchan E, Huestis M (2002) Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem 48(10):1703–1714CrossRef
19.
Zurück zum Zitat Cook C, Jeffcoat A, Hill J, Pugh D, Patetta P, Sadler B, White W, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21(4):717–723PubMed Cook C, Jeffcoat A, Hill J, Pugh D, Patetta P, Sadler B, White W, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21(4):717–723PubMed
21.
Zurück zum Zitat Judicial System Department (2018) Kotosaibansho Keijisaiban Sokuho-shu.Ministry of Justice ; Japan Hosokai; 69 Judicial System Department (2018) Kotosaibansho Keijisaiban Sokuho-shu.Ministry of Justice ; Japan Hosokai; 69
22.
Zurück zum Zitat Shima N, Nitta A, Kamata T, Sasaki K, Matsuta S, Ishikawa A, Asai R, Wada M, Kakehashi H, Nakano S, Kamata H, Sato T, Tsuchihashi H, Miki A, Katagi M (2019) Incorporation of Zolpidem and Methoxyphenamine Into White Hair Strands After Single Administrations: Influence of Hair Pigmentation on Drug Incorporation. Forensic Sci Int 301:67–75. https://doi.org/10.1016/j.forsciint.2019.05.013CrossRefPubMed Shima N, Nitta A, Kamata T, Sasaki K, Matsuta S, Ishikawa A, Asai R, Wada M, Kakehashi H, Nakano S, Kamata H, Sato T, Tsuchihashi H, Miki A, Katagi M (2019) Incorporation of Zolpidem and Methoxyphenamine Into White Hair Strands After Single Administrations: Influence of Hair Pigmentation on Drug Incorporation. Forensic Sci Int 301:67–75. https://​doi.​org/​10.​1016/​j.​forsciint.​2019.​05.​013CrossRefPubMed
32.
Zurück zum Zitat Inoue T, Niwaguchi T, Emoto M (1980) Studies on metabolism of methamphetamine analogs III Urinary excretion of methoxyphenamine and its metabolites. Rep Natl Res Inst Police Sci Res Forensic Sci 33(2):89–93 Inoue T, Niwaguchi T, Emoto M (1980) Studies on metabolism of methamphetamine analogs III Urinary excretion of methoxyphenamine and its metabolites. Rep Natl Res Inst Police Sci Res Forensic Sci 33(2):89–93
33.
Zurück zum Zitat Aviado D Jr, Wnuck A, Beer E (1958) Cardiovascular effects of sympathomimetic bronchodilators; epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamine. J Pharmacol Exp Ther 122(3):406–417PubMed Aviado D Jr, Wnuck A, Beer E (1958) Cardiovascular effects of sympathomimetic bronchodilators; epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamine. J Pharmacol Exp Ther 122(3):406–417PubMed
Metadaten
Titel
Comparative study between active and passive exposure of methamphetamine vapor in mice
verfasst von
Kazumasa Abe
Asuka Kaizaki-Mitsumoto
Satoshi Numazawa
Publikationsdatum
12.03.2021
Verlag
Springer Singapore
Erschienen in
Forensic Toxicology / Ausgabe 2/2021
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-021-00570-1

Weitere Artikel der Ausgabe 2/2021

Forensic Toxicology 2/2021 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …